Edwards Lifesciences Corporation (EW) is listed on NYSE in Medical Device Stocks. It is $90.19, +0.27%, with a $52.0B market cap. RSI is 55.1, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 55.1 Neutral
Market Cap $52.0B
Volume 1.0M
Fundamentals — 10-Q Q2 2026
Revenue $3.4B
Net Income $622.6M
EPS $1.07
Gross Margin 77.7%
Operating Margin 29.2%
Net Margin 18.4%
Debt / Equity 0.1x
P/E Ratio 84.3x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Bruls Annette | CVP, EMEACLA | Sell | 2,644 | $89.98 | $237,907 | 2026 Aug 28 |
| Chopra Daveen | CVP, TMTT, Surgical & IHFM | Sell | 31,800 | $91.02 | $2.9M | 2026 Aug 26 |
| Markowitz Wayne | CVP, JAPAC | Sell | 1,240 | $91.47 | $113,417 | 2026 Aug 26 |
| Lippis Daniel J. | CVP, TAVR | Sell | 619 | $92.03 | $56,967 | 2026 Aug 11 |
| Markowitz Wayne | CVP, JAPAC | Sell | 146 | $86.03 | $12,588 | 2026 Jul 30 |
| Markowitz Wayne | CVP, JAPAC | Sell | 9,628 | $85.06 | $818,958 | 2026 Jul 28 |
| Zovighian Bernard J | CEO | Sell | 2,921 | $83.93 | $245,134 | 2026 Jul 27 |
| Lippis Daniel J. | CVP, TAVR | Sell | 619 | $91.70 | $56,762 | 2026 Jul 10 |
| Lippis Daniel J. | CVP, TAVR | Sell | 619 | $91.40 | $56,577 | 2026 Jun 30 |
| Zovighian Bernard J | CEO | Sell | 523 | $87.92 | $45,982 | 2026 Jun 17 |
| Dahl Andrew M. | SVP, Corporate Controller | Sell | 568 | $86.08 | $48,853 | 2026 May 29 |
| Bobo Donald E JR | CVP,Strategy/Corp Development | Sell | 23,145 | $86.42 | $2.0M | 2026 May 27 |
| Chopra Daveen | CVP, TMTT & Surgical | Sell | 1,500 | $84.60 | $126,905 | 2026 May 22 |
| Lippis Daniel J. | CVP, TAVR | Sell | 620 | $81.14 | $50,307 | 2026 May 18 |
| Bobo Donald E JR | CVP,Strategy/Corp Development | Sell | 17,968 | $81.96 | $1.5M | 2026 May 15 |
| Zovighian Bernard J | CEO | Sell | 36,351 | $77.93 | $2.8M | 2026 May 12 |
| Markowitz Wayne | CVP, JAPAC | Sell | 593 | $79.73 | $47,280 | 2026 May 11 |
| Lippis Daniel J. | CVP, TAVR | Sell | 2,038 | $83.49 | $170,160 | 2026 May 4 |
| Ullem Scott B. | CVP, Chief Financial Officer | Sell | 13,000 | $80.04 | $1.0M | 2026 Apr 9 |
| Lippis Daniel J. | CVP, TAVR | Sell | 1,019 | $80.98 | $82,523 | 2026 Apr 6 |
Other Medical Device Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $46.83 | 45.9 | $67.9B |
| | $330.77 | 51.3 | $126.9B |
| | $91.21 | 57.7 | $116.7B |
| | $90.82 | 63.9 | $34.3B |
| | $35.28 | 47.1 | $29.6B |
| | $189.57 | 74.2 | $51.6B |
| | $240.31 | 72.0 | $34.7B |
| | $71.72 | 56.2 | $32.6B |
Take EW further
- Browse Medical Device Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put EW in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Edwards Lifesciences Corporation next reports.
Set alerts on EW
Get notified when Edwards Lifesciences Corporation hits your price targets or technical conditions are met.
Get Started Free